- Home
- ASST vs SRPT Comparison
ASST vs SRPT Comparison
Compare ASST & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASST
- SRPT
- Stock Information
- Founded
- ASST 2020
- SRPT 1980
- Country
- ASST United States
- SRPT United States
- Employees
- ASST N/A
- SRPT N/A
- Industry
- ASST Computer Software: Prepackaged Software
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- ASST Technology
- SRPT Health Care
- Exchange
- ASST Nasdaq
- SRPT Nasdaq
- Market Cap
- ASST 1.7B
- SRPT 1.9B
- IPO Year
- ASST 2023
- SRPT 1997
- Fundamental
- Price
- ASST $1.25
- SRPT $23.45
- Analyst Decision
- ASST
- SRPT Hold
- Analyst Count
- ASST 0
- SRPT 30
- Target Price
- ASST N/A
- SRPT $36.56
- AVG Volume (30 Days)
- ASST 119.0M
- SRPT 5.3M
- Earning Date
- ASST 11-13-2025
- SRPT 11-03-2025
- Dividend Yield
- ASST N/A
- SRPT N/A
- EPS Growth
- ASST N/A
- SRPT N/A
- EPS
- ASST N/A
- SRPT N/A
- Revenue
- ASST $4,953,567.00
- SRPT $2,481,531,000.00
- Revenue This Year
- ASST N/A
- SRPT $9.68
- Revenue Next Year
- ASST N/A
- SRPT N/A
- P/E Ratio
- ASST N/A
- SRPT N/A
- Revenue Growth
- ASST 49.00
- SRPT 64.89
- 52 Week Low
- ASST $0.34
- SRPT $10.42
- 52 Week High
- ASST $13.42
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- ASST 39.17
- SRPT 58.16
- Support Level
- ASST $0.78
- SRPT $21.29
- Resistance Level
- ASST $1.81
- SRPT $24.38
- Average True Range (ATR)
- ASST 0.19
- SRPT 1.09
- MACD
- ASST 0.16
- SRPT -0.01
- Stochastic Oscillator
- ASST 44.34
- SRPT 73.25
About ASST Asset Entities Inc. Class B
Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.